EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases

• 收藏
• 分享

专利权人:

Detlef Kozian

发明人:

Detlef Kozian,Matthias Herrmann

申请号：

US13015994

公开号：

US08211427B2

申请日:

2011.01.28

申请国别(地区):

US

年份:

2012

代理人:

摘要：

The present invention refers to human EGLN2 variants having at position 58 of the amino acid sequence a serine or a leucine and their use in the prevention or treatment of thromboembolic or coronary heart diseases, in particular stroke, prolonged reversible ischemic neurological deficit (PRIND), transitoric ischemic attack (TIA), myocardial infarction and/or early myocardial infarction.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/